Form 4 for ARCT Arcturus Therapeutics Holdings Inc.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-02 · accession 0001193805-23-001361 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-04 | 2023-10-02 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $25.61 | -5,000 | 504.4K | -1.0% | -$128.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-02 | S | D | 5,000 | $25.61 | 504,448 | D | — | — | (F2) Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on October 2, 2023, with sale prices ranging from $25.29 to $26.32 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |